Bank of America’s RayzeBio, Inc. Common Stock RYZB Stock Holding History

Bank of America’s Portfolio RYZB Stock Details RYZB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-26,461	Closed	-$1.65M	–	8362
2023 Q4	$1.65M	Buy	+26,461	New	+$658K	﹤0.01%	4579

Bank of America's RYZB Position: Q1 2024 in Review

Bank of America sold out of RayzeBio, Inc. Common Stock (RYZB) in Q1 2024, closing a stake of 26,461 shares — an estimated $1.65M sold.

Bank of America first reported a position in RYZB in Q4 2023 and held it in 1 quarter. The position peaked at $1.65M in Q4 2023. 0 funds tracked by Wall St. Rank hold RYZB as of Q1 2024.

Bank of America reported no remaining RayzeBio, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Bank of America sold 26,461 RayzeBio, Inc. Common Stock shares in Q1 2024, an estimated $1.65M.
Bank of America first reported a position in RayzeBio, Inc. Common Stock in Q4 2023 and held it in 1 quarter.
Bank of America's RayzeBio, Inc. Common Stock position peaked at $1.65M in Q4 2023.
0 funds tracked by Wall St. Rank held RayzeBio, Inc. Common Stock as of Q1 2024.

Based on Bank of America's 13F filing for Q1 2024, filed 15 May 2024.